Saturday 17 October 2026
Export MPLT’s income statement to Excel — free account
MapLight Therapeutics, Inc.
MPLT Healthcare Biotechnology
In the quarter to June 2026, EPS grew 96.6% and free cash flow fell 31.9%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
7.70
0.32
−3.99%
Follow MPLT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (297.18%) | 0.00% | 0.00% | 0.00% |
+4 more TTM periods Free account |
|
| (124.79%) | (95.27%) | (67.22%) | (78.24%) | ||
ROIC |
(348.44%) | (146.32%) | (68.95%) | (1,049.52%) | |
Return on Tangible Assets |
(76.53%) | (63.55%) | (52.06%) | (44.21%) | |
Free Cash Flow per Share |
(3.85) | (3.63) | (15.98) | (143.68) | |
Free Cash Flow |
(175.12) | (164.26) | (138.72) | (113.66) | |
Capital Expenditures |
(0.45) | (0.50) | (0.58) | (0.87) | |
| Other line items | |||||
Cash ROIC |
(26.82%) | (23.14%) | (18.17%) | (24.67%) | |
Accounts Payable Turnover |
0.00 | — | — | — | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.76 | 0.82 | 0.86 | 1.12 | |
Depreciation/Fixed assets |
(3.78) | (2.15) | (1.39) | (0.51) | |
Capex/Depreciation |
0.14 | 0.24 | 0.38 | 1.98 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(3.84) | (3.62) | (15.91) | (142.58) | |
Capex per Share |
(0.01) | (0.01) | (0.07) | (1.10) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates